02170nas a2200325 4500000000100000008004100001260001200042653002300054100001500077700001300092700001500105700001500120700001700135700001300152700001000165700001500175700001200190700001300202700001900215700001700234700001200251700001200263700001000275245005800285856009900343300000800442490000700450520137300457022001401830 2024 d c03/202410aAsia Dengue Summit1 aSrisawat N1 aGubler D1 aPangestu T1 aLimothai U1 aThisyakorn U1 aIsmail Z1 aGoh D1 aCapeding M1 aBravo L1 aYoksan S1 aTantawichien T1 aHadinegoro S1 aRafiq K1 aPicot V1 aOoi E00aProceedings of the 6th Asia Dengue Summit, June 2023. uhttps://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0012060&type=printable a1-90 v183 a

The 6th Asia Dengue Summit (ADS) themed "Road Map to Zero Dengue Death" was held in Thailand from 15th-16th June 2023. The summit was hosted by Tropical Medicine Cluster, Chulalongkorn University, Bangkok, Thailand in conjunction with Queen Saovabha Memorial Institute, The Thai Red Cross Society; Faculty of Tropical Medicine, Mahidol University; and the Ministry of Public Health. The 6th ADS was convened by Asia Dengue Voice and Action (ADVA); Global Dengue and Aedes Transmitted Diseases Consortium (GDAC); Southeast Asian Ministers of Education Tropical Medicine and Public Health Network (SEAMEO TROPMED); Fondation Mérieux (FMx) and the International Society for Neglected Tropical Diseases (ISNTD). Dengue experts from academia and research, and representatives from the Ministries of Health, Regional and Global World Health Organization (WHO) and International Vaccine Institute (IVI) participated in the three-day summit. With more than 51 speakers and 451 delegates from over 24 countries, 10 symposiums, and 2 full days, the 6th ADS highlighted the growing threat of dengue and its antigenic evolution, flagged the urgent need to overcome vaccine hesitancy and misinformation crisis, and focused on dengue control policies, newer diagnostics, therapeutics and vaccines, travel-associated dengue, and strategies to improve community involvement.

 a1935-2735